NCT00112034View on ClinicalTrials.gov

"AVONEX® Combination Trial - ACT"

PHASE4CompletedINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

May 31, 2007

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Methotrexate

DRUG

IV methylprednisolone

Trial Locations (1)

44195

MS Academic Coordinating Center, Cleveland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY